TDOC - Teladoc Health, Inc.
NYSE
->
Healthcare
->
Health Information Services
Purchase,
United States
Type: Equity
TDOC price evolution
TDOC
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1162.38 | $1097.93 | $1123.67 | |
| Short term investments | ||||
| Net receivables | $223.54 | $218.42 | $214.29 | $217.42 |
| Inventory | $36.99 | $34.9 | $32.27 | $29.51 |
| Total current assets | $1608.64 | $1546.65 | $1486.27 | $1489.05 |
| Long term investments | ||||
| Property, plant & equipment | $62.15 | $64.87 | $67.06 | $72.09 |
| Goodwill & intangible assets | $1830.69 | $2687.43 | $2750.97 | |
| Total noncurrent assets | $1976.98 | $2834.49 | $2903.32 | |
| Total investments | ||||
| Total assets | $3528.58 | $3523.64 | $4320.76 | $4392.37 |
| Current liabilities | ||||
| Accounts payable | $37.8 | $56.11 | $37.67 | $43.64 |
| Deferred revenue | $107.18 | $116.23 | $109.28 | |
| Short long term debt | $550.72 | |||
| Total current liabilities | $931.38 | $930.73 | $388.84 | $420.62 |
| Long term debt | $990.55 | $1027.4 | $1579.52 | $1581.53 |
| Total noncurrent liabilities | $1090.83 | $1643.01 | $1645.68 | |
| Total debt | $1578.12 | $1579.52 | $1581.53 | |
| Total liabilities | $2020.88 | $2021.55 | $2031.86 | $2066.3 |
| Shareholders' equity | ||||
| Retained earnings | -$16181.49 | -$16148.22 | -$15310.54 | -$15228.66 |
| Other shareholder equity | -$37.11 | -$38.97 | -$38.63 | -$36.99 |
| Total shareholder equity | $1502.09 | $2288.9 | $2326.07 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1123.67 | $918.18 | $893.48 | $733.32 |
| Short term investments | $2.54 | $53.24 | ||
| Net receivables | $217.42 | $235.65 | $168.96 | $169.28 |
| Inventory | $29.51 | $56.34 | $73.08 | $56.5 |
| Total current assets | $1489.05 | $1315.39 | $1225.44 | $1059.61 |
| Long term investments | ||||
| Property, plant & equipment | $72.09 | $71.47 | $74.01 | $75.2 |
| Goodwill & intangible assets | $2750.97 | $2909.95 | $16414.45 | $16602.12 |
| Total noncurrent assets | $2903.32 | $3029.97 | $16509.17 | $16695.67 |
| Total investments | $2.54 | $53.24 | ||
| Total assets | $4392.37 | $4345.35 | $17734.61 | $17755.28 |
| Current liabilities | ||||
| Accounts payable | $43.64 | $47.69 | $47.26 | $46.03 |
| Deferred revenue | $109.28 | $94.33 | $79.4 | $54.8 |
| Short long term debt | $11.38 | $13.31 | $56.01 | |
| Total current liabilities | $420.62 | $399.77 | $331.01 | $332.65 |
| Long term debt | $1581.53 | $1543.37 | $1276.73 | $1432.66 |
| Total noncurrent liabilities | $1645.68 | $1637.84 | $1357.84 | $1538.83 |
| Total debt | $1581.53 | $1592.79 | $1290.05 | $1488.67 |
| Total liabilities | $2066.3 | $2037.61 | $1688.85 | $1871.48 |
| Shareholders' equity | ||||
| Retained earnings | -$15228.66 | -$15008.29 | -$1421.45 | -$992.66 |
| Other shareholder equity | -$36.99 | -$42.78 | -$6.29 | $18.52 |
| Total shareholder equity | $2326.07 | $2307.74 | $16045.76 | $15883.8 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $640.51 | $642.44 | $646.13 | $660.53 |
| Cost of revenue | $188.06 | $194.54 | $193.42 | |
| Gross Profit | $460.76 | $454.38 | $451.59 | $467.1 |
| Operating activities | ||||
| Research & development | $76.75 | $81.39 | $89.94 | |
| Selling, general & administrative | $330.26 | $349.39 | $309.56 | |
| Total operating expenses | $501.13 | $1295.53 | $538.72 | $502.18 |
| Operating income | -$841.15 | -$87.12 | -$35.08 | |
| Income from continuing operations | ||||
| EBIT | -$828.14 | -$73.55 | -$19.84 | |
| Income tax expense | $0.78 | $3.88 | $2.69 | $3.52 |
| Interest expense | $9.67 | $5.65 | $5.65 | $5.54 |
| Net income | ||||
| Net income | -$33.28 | -$837.67 | -$81.89 | -$28.89 |
| Income (for common shares) | -$837.67 | -$81.89 | -$28.89 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2602.41 | $2406.84 | $2032.71 | $1093.96 |
| Cost of revenue | $760.03 | $743.99 | $650.26 | $390.83 |
| Gross Profit | $1842.38 | $1662.85 | $1382.45 | $703.13 |
| Operating activities | ||||
| Research & development | $348.52 | $333.63 | $311.88 | $164.94 |
| Selling, general & administrative | $1367.29 | $1300.56 | $1105.31 | $886.88 |
| Total operating expenses | $2090.94 | $15316.07 | $1648.08 | $1209.55 |
| Operating income | -$248.55 | -$13653.21 | -$265.63 | -$506.42 |
| Income from continuing operations | ||||
| EBIT | -$197.33 | -$13654.07 | -$304.29 | -$515.5 |
| Income tax expense | $0.76 | -$3.81 | $44.14 | -$90.86 |
| Interest expense | $22.28 | $9.27 | $80.36 | $60.49 |
| Net income | ||||
| Net income | -$220.37 | -$13659.53 | -$428.79 | -$485.14 |
| Income (for common shares) | -$220.37 | -$13659.53 | -$428.79 | -$485.14 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$837.67 | -$81.89 | -$28.89 | |
| Operating activities | ||||
| Depreciation | $98.85 | $100.5 | $101.48 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $42.11 | $42.33 | $46.82 | |
| Total cash flows from operations | $88.68 | $8.92 | $130.08 | |
| Investing activities | ||||
| Capital expenditures | -$27.75 | -$35.51 | -$36.51 | |
| Investments | ||||
| Total cash flows from investing | -$94.41 | -$27.75 | -$35.51 | -$36.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $3.83 | $1.65 | $1.11 | |
| Net borrowings | ||||
| Total cash flows from financing | $6.25 | $3.81 | $1.75 | -$1.77 |
| Effect of exchange rate | $0.57 | -$0.29 | -$0.9 | $1.35 |
| Change in cash and equivalents | $120.19 | $64.74 | -$24.84 | $91.8 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$220.37 | -$13659.53 | -$428.79 | -$485.14 |
| Operating activities | ||||
| Depreciation | $351.32 | $270.64 | $219.62 | $78.09 |
| Business acquisitions & disposals | -$78.66 | -$567.43 | ||
| Stock-based compensation | $201.55 | $217.85 | $302.59 | $475.53 |
| Total cash flows from operations | $350.02 | $189.29 | $193.99 | -$53.51 |
| Investing activities | ||||
| Capital expenditures | -$156.35 | -$172.76 | -$63.93 | -$26.04 |
| Investments | $2.51 | $60.9 | $2.5 | |
| Total cash flows from investing | -$156.35 | -$167.74 | -$72.98 | -$590.98 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $11.13 | $12.38 | $42.59 | $59.04 |
| Net borrowings | -$15.02 | -$16.19 | $737.78 | |
| Total cash flows from financing | $10.85 | $6.5 | $40.95 | $859.14 |
| Effect of exchange rate | $0.96 | -$3.34 | -$1.8 | $4.32 |
| Change in cash and equivalents | $204.53 | $28.05 | $161.96 | $214.65 |
News
Fundamentals
| Market cap | $1.79B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 171.94M |
| Revenue | $2.59B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$981.73M |
| Revenue Q/Q | -2.99% |
| Revenue Y/Y | N/A |
| P/E ratio | -1.82 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.69 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$5.71 |
|---|---|
| ROA | -24.91% |
| ROE | N/A |
| Debt/Equity | 0.89 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.73 |
| Quick ratio | 1.69 |